Depression and quality of life in patients with coronary artery disease

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 3, 2004, Pages 255-264

  Swenson, J Robert ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antidepressant medications; Depression; Quality of life; Short Form 36 scale

Indexed keywords

AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; BENZODIAZEPINE DERIVATIVE; BUPROPION SR; CITALOPRAM; CORTICOSTEROID DERIVATIVE; CYTOCHROME P450 2D6; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYPOCHOLESTEROLEMIC AGENT; NORTRIPTYLINE; PAROXETINE; SERTRALINE; VENLAFAXINE; VENLAFAXINE XR; WARFARIN;

AGITATION; ANGINA PECTORIS; ATHEROSCLEROSIS; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSTIPATION; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG HALF LIFE; DRUG POTENTIATION; HAMILTON SCALE; HEADACHE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; INSOMNIA; MAJOR DEPRESSION; MORBIDITY; MORTALITY; NAUSEA; NERVOUSNESS; ORTHOSTATIC HYPOTENSION; POPULATION RESEARCH; PROGNOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TREMOR; XEROSTOMIA;

EID: 2942609313     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.4.3.255     Document Type: Review

References (87)

1. Koike AK, Unutzer J, Wells KB. Improving the care for depression in patients with comorbid medical illness. Am. J. Psychiatry 159, 1738-1745 (2002).
2. Simon GE. Social and economic burden of mood disorders. Biol. Psychiatry 54, 208-215 (2003).
3. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms and general medical illness. Biol. Psychiatry 54, 216-226 (2003).
4. Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 262, 914-919 (1989).
5. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91, 999-1005 (1995).
6. Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom. Med. 63, 221-230 (2001).
7. Ladwig KH, Roll G, Briehardt G, Budde T, Borggrefe M. Post infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 343, 20-23 (1994).
8. Mayou RA, Gill D, Thompson DR et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom. Med. 62, 212-219 (2000).
9. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12 month outcome: a prospective study. Lancet 358, 1766-1771 (2001).
10. Pirraglia PA, Peterson JC, Williams-Russo P, Gorkin L, Charlson ME. Depressive symptomatology in coronary artery bypass graft surgery patients. Int. J. Geriatr. Psych. 14, 668-680 (1999).
11. Blumenthal JA, Lett HS, Babyak MA et al Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362, 604-609 (2003).
12. Ladwig KH, Lehmacher W, Roth R, Breithardt G, Budde TH, Borggrefe M. Factors which provoke post infarction depression: results from the Post-Infarction Late Potential Study (PILP). J. Psychosom. Res. 36, 723-729 (1992).
13. Brummett BH, Babyak MA, Barefoot JC et al. Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study. Pychosom. Med. 60, 707-713 (1998).
14. Gonzalez MB, Snyderman TB, Colket JT et al. Depression in patients with coronary artery disease. Depression 4, 57-62 (1996).
15. Lespérance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med. 58, 99-110 (1996).
16. Koenig HG. Differences in psychosocial and health correlates of major and minor depression in medically ill older adults. J. Am. Geriatr. Soc. 45, 1487-1495 (1997).
17. Bush DE, Ziegelstein RC, Tayback M et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 88, 337-341 (2001).
18. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen. Hosp. Psych. 18, 61-65 (1996).
19. Anda R, Williamson D, Jones D et al. Depressed affect, hopelessness and the risk of ischemic heart disease in a cohort of US adults. Epidemiolgy 4, 285-294 (1993).
20. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang N-Y, Klag MJ. Depression is a risk factor for in men. The Precursors Study. Arch. Intern. Med. 158, 1422-1426 (1998).
21. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom. Med. 65, 201-210 (2003).
22. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am. J. Prev. Med. 23, 51-61 (2002).
23. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 270, 1819-1825 (1993).
24. Ariyo AA, Haan M, Tangen CM et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 102, 1773-1779 (2000).
25. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. 5-year risk of cardiac mortality in relation to initial severity and 1 year changes in depression symptoms after myocardial infarction. Circulation 105, 1049-1053 (2002).
26. Wassertheil-Smoller S, Shumaker S, Ockene J et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch. Intern. Med. 164, 289-298 (2004).
27. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch. Intern. Med. 160, 1354-1360 (2000).
28. Strik JJMH, Denollet J, Lousberg R. Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased healthcare comsumption after myocardial infarction. J. Am. Coll. Cardiol. 42 (10), 1801-1807 (2003).
29. Irvine J, Basinski A, Baker B et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Pychosom. Med. 61, 729-737 (1999).
30. Kaufmann MW, Fitzgibbons JP, Suusman EJ et al. Relation between myocardial infarction, depression, hostility and death. Am. Heart J. 138, 549-554 (1999).
31. Lane D, Carroll D, Lip GYH. Anxiety, depression and prognosis after myocardial infarction. Is there a causal association? J. Am. Coll. Cardiol. 42(10), 1808-1810 (2003).
32. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Epidemiology, biology and treatment. Arch. Gen. Psychiatry 55, 580-592 (1998).
33. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry 54, 248-261 (2003).
34. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography, Atherosclerosis 26, 151-162 (1977).
35. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur. Heart J. 19(Suppl. F), F62-F71 (1998).
36. Carney RM, Blumenthal JA, Stein PK et al. Depression, heart rate variability and acute myocardial infarction. Circulation 104, 2024-2028 (2001).
37. Appels A, Bar FW, Bar J, Bruggemen C, de Baets M. Inflammation, depressive symptomatology and coronary artery disease. Pychosom. Med. 62, 601-605 (2000).
38. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Pychosom. Med. 63, 531-544 (2001).
39. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adult obesity. Pediatrics 109, 497-504 (2002).
40. Rosal MC, Ockene JK, Ma Y et al. Behavioral risk factors among members of a health maintenance organization. Prev. Med. 33, 586-594 (2001).
41. Glassman A, Helzer J, Covey LS et al. Smoking, smoking cessation and major depression. JAMA 264, 1546-1549 (1990).
42. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160, 2101-2107 (2000).
43. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Pychol. 14, 88-90 (1995).
44. Lane D, Carroll D, Ring C, Beevers DG, Lip GHY. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J. Pychosom. Res. 51, 497-501(2001).
45. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med. 160(12), 1818-1823 (2000).
46. Romanelli J, Fauerbach JA, Bush DE, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. J. Am. Geriatr. Soc. 50, 817-822 (2002).
47. Wenger NK. Improvement of quality of life in the framework of cardiac rehabilitation. In: Clinical Cardiac Rehabilitation. A Cardiologist's Guide. Second Edition. Pashkow FJ, Dafoe WA (Eds). Williams & Wilkins, MD, USA, 43-51 (1999).
48. Lesérance F, Frasure-Smith N. The seduction of death. Pychosom. Med. 61, 18-19 (1999).
49. Swenson JR, Clinch JJ. Assessment of quality of life in patients with cardiac disease: the role of psychosomatic medicine. J. Pychosom. Res. 48, 405-415 (2000).
50. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36). Conceptual framework and item selection. Med. Care 30, 473-483 (1992).
51. Hopman WM, Towheed T, Anastassiades T et al. Canadian normative data for the SF-36 health survey. CMAJ 163, 265-271 (2000).
52. Miller IW, Keitner GI, Schatzberg AF et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J. Clin. Psychiatry 59, 608-619 (1998).
53. Komaroff AL, Fagioli LR, Doolittle TH et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am. J. Med. 101, 281-290 (1996).
54. Pilote L, Lauzon C, Huynh T et al. Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography. Arch. Intern. Med. 162, 553-559 (2002).
55. Rinfret S, Grines CL, Cosgrove RS et al. Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. J. Am. Coll. Cardiol. 38, 1614-1621 (2001).
56. Swenson JR, O'Connor CM, Barton D et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am. J. Cardiol, 92, 1271-1276 (2003).
57. Hunt SM, McKenna SP, McEwan J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J. Epidemiol. Commun. Health 34, 281-286 (1980).
58. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med. Care 19, 787-805 (1981).
59. Kim C, Bernstein SJ. Quality of life assessment for chronic stable angina. Expert Rev. Pharmacoeconomics Outcomes Res. 3(5), 637-650 (2003).
60. Spertus JA, Winder JA, Dewhurst T et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J. Am. Coll. Cardiol. 25, 333-341 (1995).
61. Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction. Qual. Life Res. 5 (1), 151-161 (1996).
62. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life. The Heart and Soul Study. JAMA 290, 215-221 (2003).
63. Rumsfeld JS, Magid DJ, Plomondon ME et al. History of depression, angina and quality of life after acute coronary syndromes. Am. Heart J. 145, 493-499 (2003).
64. Spiegel D. Cancer and depression. Br. J. Pychiatry 168(Suppl. 30), 109-116 (1996).
65. Frasure-Smith N, Lespérance F, Gravel G et al. Social support, depression and mortality during the first year after myocardial infarction. Circulation 101, 1919-1924 (2000).
66. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The Enhancing Recovery in Coronory Heart Disease Patients (ENRICHD) randomized trial. JAMA 289, 3106-3116 (2003).
67. Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, Lespérance F. An open label trial of interpersonal psychotherapy, with or without antidepressant medication, in depressed patients with coronary disease. Psychosomatics (2004) (In Press).
68. Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J. Pychosom Res. 47, 131-143 (1999).
69. Roose SP. Treatment of depression in patients with heart disease. Biol. Psychiatry 54, 262-268 (2003).
70. Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV. Cardiovascular effects of bupropion in depressed patients with heart disease. Am. J. Psychiatry 148, 512-516 (1991).
71. Askinazi C. SSRI treatment of depression with comorbid cardiac disease. Am. J. Psychiatry 153, 135-136 (1996).
72. Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J. Pychiatry 155, 660-665 (1998).
73. Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279, 287-291 (1998).
74. Shapiro PA, Lespérance F, Frasure-Smith N et al. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Am. Heart J. 137, 1100-1106 (1999).
75. Strik JJMH, Honig A, Lousberg R et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med. 62, 783-789 (2000).
76. Glassman AH, O'Connor CM, Califf RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288, 701-709 (2002).
77. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 269, 2673-2675 (1993).
78. McElroy SL, Keck PE, Friedman LM. Minimizing and managing antidepressant side effects. J. Clin. Psych. 56(Suppl. 2), 49-55 (1995).
79. Beliles K, Stoudemire A. Psychopharmacologic treatment of depression in the medically ill. Psychosomatics 39, S2-S19 (1998).
80. Sayal KS, Dunca-McConnell DA, McConnell HW, Taylor DM. Psychotropic interactions with warfarin. Acta Psychiatr. Scand 102, 250-255 (2000).
81. Linden W Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch. Intern. Med. 156, 745-752 (1996).
82. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104, 1894-1898 (2001).
83. Serebruany VL, Glassman AH, Malinin AI et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. The SADHART platelet substudy, Circulation 108, 939-944 (2003).
84. Pollock BG, Laghrissi-Tbode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J. Clin. Psychopharmacol. 20, 137-140 (2000).
85. Coulehan J, Schulberg HC, Block MR, Maedonia MJ, Rodriguez E. Treating depressed primary care patients improves their physical, mental and social functioning. Arch. Intern. Med. 157, 1113-1120 (1997).
86. Lespérance F, Frasure-Smith N. Depression and coronary artery disease: time to move from observation to trials. CMAJ 168 (5), 570-571 (2003).
87. Kaufmann PG. Depression in cardiovascular disease: can the risk be reduced? Biol. Pychiatry 54, 187-190 (2003).